spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online March 2, 2004
doi: 10.1242/10.1242/jcs.01111


Journal of Cell Science 117, 989-998 (2004)
Published by The Company of Biologists 2004
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frame, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frame, M. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Newest findings on the oldest oncogene; how activated src does it

Margaret C. Frame

Cancer Research UK Beatson Laboratories, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK



View larger version (53K):

[in a new window]
 
Fig. 1. v-Src, or activated Src527F, induces tyrosine phosphorylation of cell-cell adherens junction components (the cadherin/catenin system), or acts by phosphorylating protein regulators of adherens junctions, such as Hakai, to cause disruption, or weakening, of cell-cell adhesions. Internalised cadherin molecules and released binding proteins are indicated. In a somewhat analogous manner, oncogenic Src weakens the links between cell-matrix adhesions and the actin cytoskeleton in the cell interior, in some situations by causing phosphorylation of the integrin cytoplasmic tails, but also by phosphorylating R-Ras and causing a change in integrin activation status.

 


View larger version (57K):

[in a new window]
 
Fig. 2. Some of the major v-Src effector pathways (discussed in the text) that control and co-ordinate key cellular responses, including growth and survival, adhesion/actin dynamics, matrix-degrading enzyme production and invasion. This does not represent an exhaustive list of v-Src activities in transformed cells.

 


View larger version (70K):

[in a new window]
 
Fig. 3. Epithelial cells that are held together by intercellular contacts (top-left), and shown for cells from the KM12C colon cancer cell series (visualized by immunofluorescence) (top right), become dispersed as a consequence of expression of Src527F (bottom-left), shown for KM12C cells (bottom-right). As described in the text, cadherin-dependent cell-cell contacts are lost and assembly of integrin-associated adhesions are enhanced as a result of oncogenic Src, resulting in the `adhesion switch' phenotype associated with acquisition of a more mesenchymal-like morphology. Cells in the top-right and bottom-right panels are stained with anti-E-cadherin and anti-vinculin, respectively. Images are courtesy of Egle Avizienyte.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




© The Company of Biologists Ltd 2004